AIM: The aim of the study was to evaluate efficiency of @entity101 urgency treatment using inhibitors of a1-adrenergic receptors and @entity7774 converting enzyme inhibitors-ACE inhibitors in the Emergency Room of Outpatient Hospital and Polyclinic "dr Mustafa   ehovic" Tuzla in relation to age, duration and severity of @entity101 . METHODS: The study was conducted from June 2011 to May 2012 and included 120 @entity1 of both sexes diagnosed with arterial @entity101 , aged 40 to 80 with verified @entity101 urgency. The @entity1 were divided into two groups: the control group treated with sublingual @entity20805 and the experimental group treated intravenously with @entity3773 . RESULTS: The results show that the largest number of @entity1 belonged to age group from 60 to 69 years (34,16%), and the average age was 58 (11). The largest number of @entity1 (38,0%) had verified @entity101 for 11 to 20 years. The average systolic/diastolic artery blood pressure at reception was 213 (19) / 130 (4) mmHg. The average systolic/diastolic artery blood pressure after the first dose of 12,5 mg @entity20805 in the control group was 177,42 (10,91) / 112,33 (3,50) mmHg, while after the first dose of 12,5 mg @entity3773 it was 179,25 (16,62) / 110,33 (8,78) mmHg. The average systolic/diastolic artery blood pressure after the second dose of 12,5 mg of @entity20805 in the control group was 152,00 (6,32) / 95,50 (3,76) mmHg, while after the second dose of 12,5 mg of @entity3773 it was 152,55 (7,17) / 95,29 (5,04) mmHg. CONCLUSION: @entity3773 is more efficient in @entity101 urgency treatment, since the decrease of middle artery pressure (MAP) in the group treated with @entity3773 was statistically significant (p<0,001). No statistical significance was found between the efficiency of @entity3773 and the @entity1 's age, while @entity20805 was more efficient in older @entity1 (p=0,02). Also, no statistically significant difference was found between the efficiency of @entity20805 and @entity3773 in relation to duration of @entity101 .

Emergency Room Treatment of XXXX Crises.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity20805 :: ('D002216', 'Chemical') :: ['captopril'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension', 'hypertensive'] @entity7774 :: ('MESH:D000809', 'Chemical') :: ['angiotensin'] @entity3773 :: ('MESH:C015568', 'Chemical') :: ['urapidil', 'Urapidil']
@entity101 :: (MESH:D006973,Disease) :: ['Hypertensive']
